Skip to content
OpenCapital
Get started

Clarivate CLVT Life Sciences & Healthcare — Goodwill impairment

Other segment segments

IP
$13.8M—
A&G
$0—

Similar metrics at other companies

Danaher logo
DHRLife Sciences — Goodwill Impairment
$0—
Ashland logo
ASHLife Sciences — Goodwill Impaired Accumulated Impairment Loss
$375M0.0%
Ashland logo
ASHLife Sciences — Goodwill Impairment And Income Loss On Acquisitions And Divestitutres Net
$0-100%
Fox Factory Holding Corp. logo
FOXFGoodwill impairment
$139.33M—
ExlService Holdings logo
EXLSHealthcare and Life Sciences — Goodwill
$189.57M0.0%
Ashland logo
ASHLife Sciences — Goodwill Gross
$841M0.0%

Other financials

Income statement

See full
Revenue$587.3M-5.5%
Gross profit$401.8M-3.8%
Operating income-$200.2M-3,001%
Net income-$268.6M-273%
EPS (diluted)-$0.42-282%

Balance sheet

See full
Cash & equivalents$217.7M-40.0%
Total debt$4.3B-7.4%
Total equity$4.5B-9.1%
Total assets$10.5B-8.2%

Cash flow

See full
Operating cash flow$98.7M-15.1%
CapEx$54.7M-17.1%
Free cash flow$44.0M-12.5%

Valuation

See full
Market cap$1.36B-46.9%
Enterprise value$5.47B-21.6%
P/S0.6×-0.5×

Profitability

See full
Gross margin66.8%+0.8pp
Operating margin-3.5%+5.5pp
Net margin-14%-2.3pp
FCF margin13.6%-0.3pp

Returns & leverage

See full
Return on equity-7.1%-0.8pp
Debt / equity1×0.0×
Current ratio0.8×-0.1×

Where this comes from

Reported directly by Clarivate in its filing.

Tagged under the XBRL concept us-gaap:GoodwillImpairmentLoss.

The official record: Clarivate’s 10-K, filed February 19, 2025, on SEC EDGAR. View the filing →

Ask your AI about Clarivate's life sciences & healthcare — goodwill impairment.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Clarivate's life sciences & healthcare — goodwill impairment?
Clarivate (CLVT) reported life sciences & healthcare — goodwill impairment of $149.1M in Q4 2024.
How has Clarivate's life sciences & healthcare — goodwill impairment changed year-over-year?
Clarivate's life sciences & healthcare — goodwill impairment increased by 156.2% year-over-year, from -$265.5M to $149.1M.
What does life sciences & healthcare — goodwill impairment mean?
This metric represents the non-cash charge recognized when the carrying value of goodwill associated with the Life Sciences & Healthcare reporting unit exceeds its implied fair value. It serves as an indicator of potential overpayment for past acquisitions or a deterioration in the long-term growth prospects and profitability of the segment. Investors monitor this to assess the accuracy of historical capital allocation and the current valuation of intangible assets.